Publications and Presentations

1. Matheou N. Efficacy and safety ofthe eyeWatch glaucoma drainage device. 130th French Society Ophthalmological Congres, 4-6/5/2024, Paris.
2. Matheou N. Catarract and Glaucoma. Management of the future. New Ophthalmic Surgery Notes 2013;7(1) 27-28
3. Matheou N., Tsipianiti I., Kranias G. Double plate Ahmed valve Model   B-1 insertion in neovascular glaucoma. Two years postoperative follow-up. 31th Panhellenic Ophthalmology Congress, Thessaloniki, Greece, 2006
4. Matheou N. N., Stavrakas I., Kranias G. Herpetic keratitis and Latanoprost. Greek Annals of Ophthalmology 2005;15(2):175-178
5. Lip PL. Felmeden DC, Blann AD, Matheou N, Thakur S, Cunliffe IA, Lip GY. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and Von Willebrand factor in glaucoma. Br J Ophthalmol 2002 Nov:86(11):1299-302
6. Matheou N, Lip PL, Felmeden D, Blann AD, Thakur S, Ramanathan S, Cunliffe IA, Lip GYH. Plasma vascular endothelial growth factor and von Willebrand factor levels in Primary Open Angle Glaucoma and Normal Tension Glaucoma. 2001 ARVO Meeting, Fort Lauderdale, Florida, USA, May 2001
7. Matheou N, Lip PL, Felmeden D, Blann AD, Thakur S, Ramanathan S, Cunliffe IA,    Lip GYH. Plasma vascular endothelial growth factor and von Willebrand factor levels in Primary Open Angle Glaucoma and Normal Tension Glaucoma. Invest Ophthalmol Vis Sci. 2001;42(4):S560  Abstract nr  3008
8. Lip PL, Felmeden D, Blann AD, Matheou N, Thakur S, Ramanathan S, Cunliffe IA, Lip GYH. Abnormal vascular endothelial growth factor and von Willebrand factor levels in glaucoma. Royal College of Ophthalmology Annual Congress, Birmingham, UK, May 2001
9. Matheou N, Ramshandani M, Cunliffe IA. Retrospective study on the use of Cosopt  in glaucoma patients.  33d Panhellenic Ophthalmological Congress, Thessaloniki, Greece, May 2000
10. Matheou N, Sedgwick G, Wild JM, Cunliffe IA. Visual field loss attributable to misting of the trial lens. Acta Ophthalmol Scand. 2000Dec;78(6):721-2
11. Matheou N, Cunliffe IA. A retrospective study on the use of Xalatan over a three year period. 6^th European Glaucoma Society Congress, London, UK, Ιούνιος 2000
12. Matheou N, Ramshandani M, Cunliffe IA. A retrospective study of the use of Cosopt in glaucoma patients. Heartlands Research Day, Birmingham, UK, November 2000
13. Matheou N, Cunliffe IA. Our changing trends in prescribing Xalatan. Heartlands Research Day, Birmingham, UK, November 2000
14. Matheou N, Rauz S, Ramchandani M, Cunliffe IA. An audit of the use of Cosopt in glaucoma patients in general ophthalmic clinics. 20^th Annual Meeting of the Glaucoma Society (UK & EIRE), London, UK, November 1999
15. Matheou N, Ahmad N. Clinical comparison of Silicone versus PMMA intraocular lences in phacoemulsification. 31st Panhellenic Ophthalmology Congress, Chalkidiki, Greece, May 1998
16. Matheou NP, Drakatos PA, Drakatos SP, Badekas V. Simulation of man-machine system for mechanical designing. 8th Annual International Energy Week Conference, American Society of Mechanical Engineers International, Houston, USA, January 1997. (co-chairman)
17. Rauz S, Sung V, Matheou N, Chew CKS et al. Activity of an Ophthalmic Accident & Emergency Department: the results of 3970 consecutive patients. Oxford Annual Ophthalmology Congress, UK,  July 1997.
18. Matheou NP, Panagiotou I. Gastroesophageal reflux. Paediatriki.1995;58:297-304